Product logins

Find logins to all Clarivate products below.


Sunita Nair

Senior Director, Systematic Literature Reviews and Meta-analysis

Sunita Nair is a Practice Head at Clarivate, leading our Systematic Literature Reviews and Meta- analysis Centre of Excellence. Sunita is a business leader with 25 years experience and provides leadership to our highly skilled team of systematic reviewers and meta-analysis experts. She has supported several US FDA and HTA submissions. She has formerly worked in tertiary hospitals and multinational pharmaceutical companies (Sanofi, Novartis) in India. She has vast experience in establishing businesses, and managing teams providing services in HEOR, medical writing and clinical development. Her core areas of interest include cardiovascular research, HEOR, knowledge management, market access, market research, medical communications, molecular diagnostics, and scientific writing.​

Sunita is a regular speaker at scientific conferences, on the review panel of several journals, and a National Executive Committee member of the ISPOR India chapter.​

Sunita has a PhD in Applied Biology (Molecular Biology) and a master’s degree in Microbiology from the University of Mumbai, and a Post-Graduate Diploma in Global Health Policy from the London School of Hygiene and Tropical Medicine. She is also trained in Knowledge Management, carried out at the Indian Institute of Management.​


arrow_forward
Get in touch with Sunita

Latest news

News November 6, 2025
Fujifilm Selects IPfolio from Clarivate

Maximizing the value of intellectual property assets to support business growth London, U.K. November 6, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that…

News October 30, 2025
Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence

Drawing on insights from over 2,000 librarians representing academic, national and public libraries globally, the report offers an up-to-date view of how they are adapting to rapid change London, U.K.,…

News October 29, 2025
Clarivate Reports Third Quarter 2025 Results

— Continued acceleration of organic ACV — — Raises 2025 Revenues Outlook — — Repurchased 11.7 million ordinary shares and repaid $100 million of debt in the third quarter—  …

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025